<SEC-DOCUMENT>0001493152-23-039866.txt : 20231108
<SEC-HEADER>0001493152-23-039866.hdr.sgml : 20231108
<ACCEPTANCE-DATETIME>20231108141619
ACCESSION NUMBER:		0001493152-23-039866
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20231107
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231108
DATE AS OF CHANGE:		20231108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Qualigen Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001460702
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				263474527
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37428
		FILM NUMBER:		231387246

	BUSINESS ADDRESS:	
		STREET 1:		2042 CORTE DEL NOGAL
		STREET 2:		CARLSBAD
		CITY:			CALIFORNIA
		STATE:			CA
		ZIP:			92011
		BUSINESS PHONE:		(760) 918-9165

	MAIL ADDRESS:	
		STREET 1:		2042 CORTE DEL NOGAL
		STREET 2:		CARLSBAD
		CITY:			CALIFORNIA
		STATE:			CA
		ZIP:			92011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RITTER PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20090402
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:QLGN="http://qualigendiagnostics.com/20231107">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_QLGN_qualigendiagnostics.com_20231107 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20231107_20231107 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001460702 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:EntityCentralIndexKey">0001460702</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="qlgn-20231107.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-11-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001460702</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-07</xbrli:startDate>
        <xbrli:endDate>2023-11-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_908_edei--DocumentType_c20231107__20231107_zyKKBDmdMGq6"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_907_edei--DocumentPeriodEndDate_c20231107__20231107_zZpt6n26UcM9"><ix:nonNumeric contextRef="AsOf2023-11-07" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 7, 2023</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90D_edei--EntityRegistrantName_c20231107__20231107_zk7dPhdOnps7"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:EntityRegistrantName">Qualigen
Therapeutics, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20231107__20231107_zTEnAQGOtet7"><ix:nonNumeric contextRef="AsOf2023-11-07" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityFileNumber_c20231107__20231107_zVfaGI4Hrtk9"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:EntityFileNumber">001-37428</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20231107__20231107_zF8d9mlNvKva"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:EntityTaxIdentificationNumber">26-3474527</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_903_edei--EntityAddressAddressLine1_c20231107__20231107_zD6U3yM0kKk4"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:EntityAddressAddressLine1">5857
Owens Avenue</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressAddressLine2_c20231107__20231107_zrGMvDxFpUCl"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:EntityAddressAddressLine2">Suite 300</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressCityOrTown_c20231107__20231107_zKVQUlnvb252"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:EntityAddressCityOrTown">Carlsbad</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20231107__20231107_zErZl5YuSkH3"><ix:nonNumeric contextRef="AsOf2023-11-07" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_908_edei--EntityAddressPostalZipCode_c20231107__20231107_zxpazMOHiBJj"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:EntityAddressPostalZipCode">92008</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices) (Zip Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_906_edei--CityAreaCode_c20231107__20231107_z8UNdC0JSprl"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:CityAreaCode">(760)</ix:nonNumeric></span>
<span id="xdx_905_edei--LocalPhoneNumber_c20231107__20231107_zE0QHNraqBZh"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:LocalPhoneNumber">452-8111</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">n/a</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--WrittenCommunications_c20231107__20231107_zUAgrafajSD4"><ix:nonNumeric contextRef="AsOf2023-11-07" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SolicitingMaterial_c20231107__20231107_zWvtZJOde5A2"><ix:nonNumeric contextRef="AsOf2023-11-07" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--PreCommencementTenderOffer_c20231107__20231107_zSnz0PrkgT5c"><ix:nonNumeric contextRef="AsOf2023-11-07" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20231107__20231107_zoDW2oUXZE3b"><ix:nonNumeric contextRef="AsOf2023-11-07" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--Security12bTitle_c20231107__20231107_zHEXWp7SfSGc"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:Security12bTitle">Common
    Stock, par value $.001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--TradingSymbol_c20231107__20231107_zLEObrXbufT6"><ix:nonNumeric contextRef="AsOf2023-11-07" name="dei:TradingSymbol">QLGN</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_904_edei--SecurityExchangeName_c20231107__20231107_zv5ON0njE9d7"><ix:nonNumeric contextRef="AsOf2023-11-07" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market of The Nasdaq Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (&#167;230.405 of this
chapter) or Rule 12b-2 of the Exchange Act (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company&#160;<span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20231107__20231107_z2qHHoc4YBtl"><ix:nonNumeric contextRef="AsOf2023-11-07" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act&#160;&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01. Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, Qualigen Therapeutics, Inc. (the &#8220;Company&#8221;) issued a press release announcing that the first patient in
the Phase 1a clinical trial of QN-302 had been dosed for the treatment of advanced or metastatic solid tumors. A copy of the press release
is attached hereto as Exhibit 99.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this Item 7.01 (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject
to the liabilities of that Section, nor shall the information in this Item 7.01 (including Exhibit 99.1 attached hereto) be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific
reference in such filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01. Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, the Company announced that the first patient in the Phase 1a clinical trial of QN-302 had been dosed for the treatment
of advanced or metastatic solid tumors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left; width: 0.1in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release, dated November 7, 2023, issued by Qualigen Therapeutics, Inc.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUALIGEN
    THERAPEUTICS, INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    November 7, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Michael S. Poirier</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    S. Poirier, Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZS03jz6JLi4pYRYqI22hHCbaZMolaj+QtjS3iMDAM733vCTEQS1qYChmOsyKHPdZNpT1CgRdktGcMjmy1TiHcAq/GedbWd+8PzCgwGJhJrOQpCJ31YRyWKSTJUE6HagRymo4V7DYi+uoZ2Ysp0XqjK9C2hB1Twwa95lefsNctWapfXdUB2RmyIS6WvfwGJRMFW3roJ/HNQZ5nIhp0E4kl070Jrnnr0X5JmFdYhzrX0/+NPgTaSoo= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 72px; width: 120px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Qualigen
Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CARLSBAD,
Calif., Nov. 7<SUP>th</SUP>, 2023 (GLOBE NEWSWIRE) &ndash; Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics
company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announces today
that the first patient in the Phase 1a clinical trial has been dosed with QN-302, a potential first-in-class, investigational G-Quadruplex
(G4)-selective transcription inhibitor designed for the treatment of advanced or metastatic solid tumors. The first clinical site is
located at START Midwest in Grand Rapids, Michigan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QN-302
works by selectively stabilizing G4 complexes prevalent in the promoter region of oncogenes in many tumor types, impeding transcription
of G4-containing cancer genes, and may potentially offer a tumor-agnostic clinical approach to treatment. It was invented and developed
by Dr. Stephen Neidle&rsquo;s team at the University College London and exclusively licensed by Qualigen in January 2022.
Qualigen received Orphan Drug Designation for the intended treatment of pancreatic cancer in January and clearance from the US FDA to
initiate a Phase 1 clinical trial in July of this year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;G-quadruplexes
are prevalent in a number of difficult-to-treat tumor types, including pancreatic cancer,&rdquo; said Sreenivasa Chandana, M.D., PhD.
Director of GI/GU medical oncology research at Cancer and Hematology Centers of Western Michigan in Grand Rapids, and an investigator
for the QN-302 Phase 1a clinical trial at START Midwest. &ldquo;QN-302 is a potentially tumor-agnostic approach that may offer a once
weekly treatment option for patients with advanced disease with a unique mechanism of action to improve patient outcomes. We are excited
to participate in the first-in-human clinical trial of QN-302 to explore this potential new treatment modality.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
QN-302 Phase 1 clinical trial is multi-site, open-label, dose-escalation and dose expansion, safety, pharmacodynamic and pharmacokinetic
study of intravenous QN-302 in patients with advanced or metastatic solid tumors. A total of up to 36 patients will be enrolled in the
dose escalation (Phase 1a) portion of the study. The exact number of patients to be enrolled will depend on the observed safety profile,
which will determine the number of patients per dose level, as well as the number of dose escalations required to meet the Maximum Tolerated
Dose (MTD). Once the MTD has been established in dose escalation, dose expansion will begin.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;The
initiation of the QN-302 Phase 1a clinical trial represents a significant milestone for Qualigen and further progress toward our goal
to offer patients new treatment options for devastating diseases, such as pancreatic cancer and other advanced solid tumors,&rdquo; commented
Tariq Arshad, M.D., M.B.A., Qualigen&rsquo;s Chief Medical Officer. &ldquo;We are grateful for the support of our CRO, TD2, as well as
study sites, investigators, and patients and families who are all working together to explore the potential of QN-302 as a novel treatment
for G4-prevalent tumors. We look forward to continuing these close partnerships as we enroll additional patients in our Phase 1a study.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
QN-302 Phase 1a clinical trial will be conducted at up to four leading clinics and medical centers in the United States. In addition
to the first site at START Midwest in Grand Rapids, Michigan, we expect to activate additional sites in Q4 this year. Qualigen anticipates
providing an update on safety and preliminary efficacy of the Phase 1a study in the first half of 2024. For more information on QN-302
or the Phase 1a clinical trial, please visit our QN-302 clinical trial <U>website</U> on ClinicalTrials.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
QN-302</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QN-302
is a small molecule G4-selective transcription inhibitor in Phase 1 clinical development for the treatment of G4-expressing solid tumors,
such as pancreatic cancer, prostate cancer, sarcomas, and others. QN-302 stabilizes G4 complexes prevalent in the promoter region of
oncogenes in many tumor types, impeding transcription of G4-containing cancer genes and may potentially offer a tumor-agnostic clinical
approach to treatment. Orphan Drug Designation was granted by the FDA in January of this year for QN-302 for the intended indication
of pancreatic cancer. The Company anticipates, subject to the Company securing additional funding, the dosing of at least 24 patients
in the Phase 1a trial can be completed by the end of 2024, funded in part by proceeds received by the divestiture of the Company&rsquo;s
diagnostics business in July 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Qualigen Therapeutics, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qualigen
Therapeutics, Inc. is a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. Our investigational
QN-302 compound is a small molecule selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells;
such binding could, by stabilizing the G4s against &ldquo;unwinding,&rdquo; help inhibit cancer cell proliferation. The investigational
compounds within Qualigen&rsquo;s family of Pan-RAS oncogene protein-protein interaction inhibitor small molecules are believed to inhibit
or block the binding of mutated RAS genes&rsquo; proteins to their effector proteins, thereby leaving the proteins from the mutated RAS
unable to cause further harm. In theory, such mechanism of action may be effective in the treatment of about one quarter of all cancers,
including certain forms of pancreatic, colorectal, and lung cancers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
news release contains forward-looking statements by Qualigen that involve risks and uncertainties and reflect the Company&rsquo;s judgment
as of the date of this release. These statements include those related to the Company&rsquo;s prospects and strategy for development
of its therapeutic drug candidates, including the anticipated timeline for the Company&rsquo;s Phase 1 clinical trial and enrolling and
dosing of patients, and the activation of additional clinical trial sites, the sharing of initial data. Actual events or results may
differ materially from the Company&rsquo;s expectations. There can be no assurance that the Company will be able to successfully develop
any drugs (including QN-302, Pan-RAS and QN-247); that preclinical development of the Company&rsquo;s drugs (including Pan-RAS and QN-247)
will be completed on any projected timeline or will be successful; that any clinical trials will be approved to begin by or will proceed
as contemplated by any projected timeline, or at all; that any future clinical trial data will be favorable or that such trials will
confirm any improvements over other products or lack negative impacts; that preclinical study results the Company observed in animals
will be borne out in human patients; that any drugs will receive required regulatory approvals (or Fast Track designation or Orphan Drug
status) or that they will be commercially successful; that patents will issue on the Company&rsquo;s owned and in-licensed patent applications;
that such patents, if any, and the Company&rsquo;s currently owned and in-licensed patents would prevent competition; or that the Company
will be able to procure or earn additional sufficient working capital to complete the development, testing and launch of the Company&rsquo;s
prospective therapeutic products (including QN-302, Pan-RAS and QN-247). The Company&rsquo;s stock price could be harmed if any of the
events or trends contemplated by the forward-looking statements fail to occur or is delayed or if any actual future event otherwise differs
from expectations. Additional information concerning these and other risk factors affecting the Company&rsquo;s business can be found
in the Company&rsquo;s prior filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K,
all of which are available at <U>www.sec.gov</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company disclaims any intent or obligation to update these forward-looking statements beyond the date of this news release, except as
required by law. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information about Qualigen Therapeutics, Inc., please visit <U>www.qlgntx.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
Relations<BR>
<U>ir@qlgntx.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source:
Qualigen Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &. I@# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"96A^&['P_I-II]O!'Y-L@1"4&>.]:M%%?,-N3NS[^,5%6BM HHHI%!1110
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MHT4<K"*:7#1]OK7Z'5\-F]'V6)<K_%J?KW#.*^L8%0M;DT"BBBO$/K HHHH
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MBBOFC[T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** *FK_ /()O>_[A_\ T$U^8/C#
M*ZY?!@4;[3+E&&"/F-?J0RAU*L,@C!%?%7[87AVQT7Q1I[VEND'GQ,[;1C)K
MZ3)*RA6=*WQ?H?"<685U<-'$)_ _S/FQC7&?$;F.WKL<XKCOB!\\<-?6UO@9
M^;8/^/$X]%XK9\,ZI+HNK6MW%(T;1RJWRGJ,\UDHM3J.E>9:Y](Y..J/U_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZGZ3PKE;3>-K1T^SW]2U1117R)^F!1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HJ%KR!3AIHP?0N*3[=;_\]XO^^Q0!/14<=Q%,<)*CGT5@
M:DH ***9),D*%I'5%'4L<4 /HKS*X_:$\*6_Q M?"#7)_M.X.$((V?G7I8D4
MG 8$^F:B-2,[\KO8Z\1A,1A5%UX./,KJ_5=QU%%%6<@4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4R3_5
MOCT-/IDO^K?Z&@#\@OCU\6/&.F?%?Q!;0^(KZ"!+A@D<4F !FO/O^%U>-O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/^\T_4_3>N4^)7Q*T3X4^%KC7]>N/(LH>/EY9CZ 5T\T\=M&TLLBQ1J,L[D
M#ZFORO\ V[OB)>Z]\6M0TRTUUKW0HT5HX(9,Q!^]?.8:A[>?*]C['&XKZK2Y
MTKLX3]H[]H[7/CAXBF%Q<YT.VG8V5MLQA>Q->+LVXYP!026;U)KH/"O@76O&
M%Q''IFGW-TI?:TD<9*K]37U48QIQLM$CX64IUI\TM6SGJ=Y9QFOM/P;_ ,$X
MM:\2>'[/4;G78[)IP&:W>/Y@/RKVRU_8,T>'PT^GO+"UT8]HGV\YQUKCEC:,
M7:]ST*>6XB:NU8_+ZG*VTYP#]:^\)O\ @F+J#2R&+Q1%&G)52F?PZ5\=_$KX
M;ZI\-?%%]H^I6\R-!,8TE>,A90.X/>MZ>(IU7:#.6MA:U!7J1LCT?]G3]J#Q
M!\$[^.QAN<Z!/-ON+?;DCW%?J9\*OBII/Q2\-6VJ:;.KB1<[<\U^'ZL5.1Q7
MO7[+?[2%[\#_ !8LD\<^I:3,HB:UW\)DXW"N3%X554YP7O?F=^ Q[P\E3J/W
M?R/U]HK.\/:NNOZ'8ZDB&)+J%9@C=0&&<5:O+ZWT^W>>ZFCMX5&2\C!0/SKY
MOR/L[Z7/.?CK\<M"^"/A>2]U:9DN;A&6U11G<^#C]:_,CXC?M>?$#XC:/J&C
MZCJJOI=TS8A52K*N>!G-=O\ MM?M%6_Q6\1?V#9VN+71[AD6Y4@ASWQ^=?*O
MWC7TF#PL804IK5GQN88V=2HX4Y>ZA7?>V< ?2FCFNW^'_P )=>^(&I6\%C8W
M!@D.#<>4=H_&OKSPO_P37U!+C3;Z^U^%X<K++;%.?7&<5UU,13I?$SSZ.%K5
M]:<=#X0^SMC-1]*_8*[_ &2?!T_AG^STTRW2ZVX\_8,U\V>+/^";.H1IJNH6
M.OQ"-%>:*U$>2<#.T'%<T,=2EOH=M3*\13UCJ?"4;;&SQ^-?2'P#_;#\5?#.
MVT[P]->"308F"JNWYDY]:\!\0^';_P ,ZC-9:A:S6L\3E"LT97.#U&>M9BL5
MKMG"%6-I:H\VG4G0GS0=F?NA\/\ QQ8^._#MIJ%G,LIDC5G /0XKIZ_+[]BW
M]J"X^'&M+X9U&VFU*UU2=(8)"^?))Z"OT_1MRJ<8R,XKY7$4'0G9['W.#Q4<
M53YENMR&_OHM-LI[N=MD$"-([>B@9-?FW^V#^V1-XZN;CPOX0O6C\/LC17;L
MF&D8'& ?SKZJ_;"^.9^#G@A(DM#=2:LK6Z@=LBOR2U"[-Y=S3$;=\C/M],DG
M%>C@,.I?O9KT/)S7%RC^XIOU(9)"_8#Z"F5+;0FXF2,'!9@H_$XK[/\ A_\
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MS'),H*Y_&OP^R5J_'KE]"H5+RY1?19V _G1B,'&N^:]F&$S">%CR6NC]R_\
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MQ_R!?"W_ %T;^M>-AX>SQ2CV9]#C*GM<"ZEMTC\[6^\:^P?^";/_ "5[4/\
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M'_!,7_D$>*_^NB_TK[,\8^#]-\<:'/I6JVRW5K*.8W'&:^,_^"8O_((\5_\
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M#_DLWBO_ *_6KS&OJ:?P1]#X:K_$EZL^L_\ @G'_ ,ELF_Z\C_6OU%K\NO\
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M^L0HZ2-MW0*2![UY?_8]WVMYC_VR;_"OW7UCPSI/B%0NIZ?;WRCH)T#5E?\
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M>?L\W_?IO\*^N/\ @G!:SV_Q@O\ ?#($^Q8+E2 #SQ7Z$_\ "K?"/_0NZ?\
M]^!5_1O!>A>';AI],TFUL9F&"\$84FNVMCU4IN'+N>;A\JE1JQJ<][&U24M%
M>,?1'C7Q"_95\ ^.HM5NKC18VU:ZC8K<'J'(X/YU\!?$_P#8:\<_#KPQJ7B"
MX^RSV%H6(CA.Z0KGCC-?K%5>^T^VU2UDMKN%+BWD&&CD&5/U%=M'%U*.B=T>
M;B,OHXC5JS/P<_L>Z;E8)6'JL;$?RH_L:[_Y]YO^_3?X5^X*_"OP@HP/#FG
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M_-W_ (*4?\E;T[_KR_\ B:^.U^\*]W_:V^.ME\<_'T>IV%B]G;6L1MUWG)<
M@9_2O"%^\*^OP\7"E&,MS\^Q<XU,1.<7=-GZ(?\ !,7_ )!'BO\ ZZ+_ $K[
MHKX6_P""8I']D^*QW\Q>/RK[IKYS&_QY'U^6_P"ZP"BBBN(],**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** ,;Q;X7L_&6AW&E7Z[K:8888S7XR_'W
MPW:^%?BKXBTNSP8+6Y,:XK]LZ^0?VN?V-[3X@6,OB/PE9PPZ^K--=[VP)E S
M^?6O2P-:-*=IO1GBYGAI5Z:E!:H_,6O2_@?\<M;^"/BJ/6-+/GA4*-;2.?+;
M/J*X/4-&NM-N;B">)DE@=DD7:?E(.*H8-?22BIJSV/CHRE3DI1=FC[H\)?\
M!17QAX@\6:7I\NCV*6MU<)"^SEAN...*_0JTF-Q:PRD8+HK'\1FOP\^$W_)1
M/#O_ %_1_P Z_<#3?^0?:_\ 7)?Y"OGL?2A2<>16/K<JKU:\9NI*]C@OC5XN
M\4^#]!ANO"VE_P!J71?$D>W.%]:^>KC]K;Q_:WR:=-H$$6I2$!(&3YF/L,5]
MCSMM@D/HI/Z5\4>-IB?VC/#K?+D3^GO71E_LJB<)TT[)NYYV=_6:$HU:-9Q4
MFE;2Q]6?#77M<U[P=!?^(;'^S]38$O!C&.*XSX,_&34?B/XN\2Z7=6L<,&F.
M51EZGYL<UZ]/_J)/]T_RKX6\ :3X[U;XG^+?^$$O$LI%N&\]Y& 7&?\ &L,-
M2AB(U6[1VMV6IU8_$5L%4PT8MSNVFEO+0^B?$OQFU+1?CAIG@Q+6-K*Z56,I
M^]R,UZYJ%P;.PN9P,F*)G'X FOBOPWI_BG2_VEM$B\9W NM6(R)%;(*\8Q7V
M?K>/[%O\]/L\G_H)J<91A1=.,>JW74TRO%5<2J\ZEU:3LGNE;8^6M+_:2^)7
MBW4M1B\.>&XM1M[65D9D7)7!(YX]J[WX3_$OXD^)/%WV'Q-X;&F:?MSYVS'-
M>#_!C2?B'JFH^)3X%U*&P@6Y?SEF<#<=QZ9K[!^&L>O6?A>UM_%%[!>:RN?,
M>%@:[<=&C03C",?QNCR<IGB<6XU*E2?5].5Z[=S@OVB?C1JOPG&DQ:3:Q7-Q
M?$J%D'&>>*Y;PC\<_B#'K%M/XO\ #RZ3X=89EO"F H/O6;^V5=KIFL>#;^1=
M\=O/YC*.I ))KF_B+\:9/CVUEX.\,K]CAN=H<7(VAF&,CZ5>'P\9T(/V::=[
MR[&>,QU2EC*R]LTX\O+!?:;1]=Z/K%GKVGQ7UA.MS:RC*2)T-<=\6_BQIGPQ
M\/W-Q-<)_:13-M;'K(W859^%7A2?X<?#G3])OI%EEL8B9'4Y' R:^2OCU\4O
M#WQ"^)FD2BWN)M(T]O*O-H(,@#<X_*N#"86-?$.*NX+^OQ/8S+,9X/!QF[1J
M2MH^C>_W'U3\#_B%=_$SP/%K%["D%PTK1E4Z<'%=?XDU1M%T&_OT7<UO"T@!
M[X%?+7P3^)T.H?&)-%\,9L/!_EDI:R_*00!_,_RKZ7\?+O\ !.M =[63^59X
MJA[&NE:R>MNR?0VR_&?6<&Y*5Y1NF^[75'S%IO[3GQ-\20W5UHGAF*^LX7VF
M2-,X]CQUKW_X6_%&T\<:;#!=2QPZ^B9N;(?>0U\L_![]H#3/A?\ #_6-$FM9
MI-2EG=HG1<KSD<FO1_V9_ASK7_"6W7CN]*I9:C&QC7HYW>HKU,9AJ<83;@H)
M;/N?/97CJ]2I24:KJN7Q)[1\SIOC_P#'+7/AIX@TO2=#L8KVYO%RJ2#))SC
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MHO\ P3#;G?XNSSQ^Z'3_ +YK[XHKIIXFK25HLXJV#H5VG.)\-^&/^";A\/\
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G<_:0TIDW?6NTHK)U9M.+>YZ$<OPU.K"M"%I03BO),****R/0/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>qlgn-20231107.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWauMebP9z5Z8SekhvWB8bYn63yIj6qLV1Sbe3bYmQSQL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:QLGN="http://qualigendiagnostics.com/20231107" elementFormDefault="qualified" targetNamespace="http://qualigendiagnostics.com/20231107">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://qualigendiagnostics.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="qlgn-20231107_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="qlgn-20231107_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>qlgn-20231107_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>qlgn-20231107_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://qualigendiagnostics.com/role/Cover" xlink:href="qlgn-20231107.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://qualigendiagnostics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139697878000064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  07,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Qualigen
Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001460702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-3474527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5857
Owens Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Carlsbad<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(760)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">452-8111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">QLGN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="qlgn-20231107.xsd" xlink:type="simple"/>
    <context id="AsOf2023-11-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001460702</identifier>
        </entity>
        <period>
            <startDate>2023-11-07</startDate>
            <endDate>2023-11-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2023-11-07">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-11-07">0001460702</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2023-11-07">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-11-07">2023-11-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-11-07">Qualigen Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-11-07">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-11-07">001-37428</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-11-07">26-3474527</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-11-07">5857 Owens Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2023-11-07">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-11-07">Carlsbad</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-11-07">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-11-07">92008</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-11-07">(760)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-11-07">452-8111</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-11-07">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-11-07">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-11-07">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-11-07">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2023-11-07">Common     Stock, par value $.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2023-11-07">QLGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2023-11-07">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-11-07">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  ER:%<'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  )<FA7^^"#F.\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M3L,P#(=?!>7>NFG1!%&7"]-.("$Q"<0M2KPMHOFCQ*C=V].6K1."!^ 8^Y?/
MGR6W.@H=$CZG$#&1Q7PSN,YGH>.:'8FB ,CZB$[E<DSXL;D/R2D:G^D 4>D/
M=4"HJVH%#DD910HF8!$7(I.MT4(G5!32&6_T@H^?J9MA1@-VZ-!3!EYR8'*:
M&$]#U\(5,,$(D\O?!30+<:[^B9T[P,[)(=LEU?=]V3=S;MR!P]O3X\N\;F%]
M)N4UCK^R%72*N&:7R:_-PV:W9;*NZJ;@O*CN=OQ>\)7@M^^3ZP^_J[ +QN[M
M/S:^",H6?MV%_ )02P,$%     @ "7)H5YE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M"  )<FA7@-"K"&@$   H$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V875/C-A2&[_D5&K?3V9T!_)%/:)*9$,*6618"2;LS[?1"L958@RVYDIS
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M='@//GL?)=-[*CG_5U/\!%!+ P04    "  )<FA7EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    (  ER:%>JQ"(6,P$
M "("   /    >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5*A^P%K0A#5%>0-N0
MI@V-B??0NM0BB2O'A8VOG]NJ&M)>]I3<V;K<7187XM.!Z)1\>1=B;FJ19IZF
ML:C!VWA'#02=5,3>BD(^IK%AL&6L <2[=)IEL]1;#&:Y&+6VG-X"$B@$*2C9
M$7N$2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R
M#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z0B? :ROP
MS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&))@G60VY6
M= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>9WK_,'G4
M'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    "  )<FA7)!Z;HJT   #X 0  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,
M75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO
M *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR
M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/
M3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ "7)H5V60>9(9 0  SP,
M !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +
M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5
M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP
M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM
M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>
M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]
M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M"  )<FA7!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    (  ER:%?[X(.8[P   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  ER:%>97)PC
M$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ "7)H5X#0JPAH!   *!$  !@              ("!#@@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  ER:%>?H!OP
ML0(  .(,   -              "  :P,  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ "7)H5Y>*NQS     $P(   L              ( !B \  %]R96QS
M+RYR96QS4$L! A0#%     @ "7)H5ZK$(A8S 0  (@(   \
M ( !<1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  ER:%<D'INBK0
M /@!   :              "  =$1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    (  ER:%=ED'F2&0$  ,\#   3              "
M ;82  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(    4
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://qualigendiagnostics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>qlgn-20231107.xsd</File>
    <File>qlgn-20231107_lab.xml</File>
    <File>qlgn-20231107_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "QLGN",
   "nsuri": "http://qualigendiagnostics.com/20231107",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "qlgn-20231107.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "qlgn-20231107_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "qlgn-20231107_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://qualigendiagnostics.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2023-11-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-11-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://qualigendiagnostics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001493152-23-039866-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-039866-xbrl.zip
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M?:56!5@2+FQ)6^[Y#2M2F!#=)Y#9@RBKK)_(B4IZ#*#[RF*L\W#LE?&,I 9
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M2#=\)X 3U'>!7+7(O5%<@J)MM-RC3GX%2JECJ/8;E J3MV0,- ESY;)UA*6
M4ZG&XMN0Y)3MP,0ETZC^3WU6H?_ N.Z'ED"?Z9!7%%<4^:<$VVC\LQ<OOGV4
MMD\O;2_I.RSW6CU<DO$=5925%@]O*=XFLZR\&\!_/1J+CW[2(XIBHW+WTYVU
MR9A]L4PXY5($R>R5\M\DV#^\HC^B\_I FW\]"N G/.EU7IE([;ZGNOKET_$'
MJ@//]\0KUS.\*\XH4GHL%OP)Q8+/D;H/@KM)?Y3+_94N^F->_P=02P,$%
M  @ "7)H5^D(>F$4$P  <YL   L   !F;W)M."UK+FAT;>T=;5?BO/*[Y_@?
M<KGWN4?/(] 6$-^6>Q!0\044\%G7+Y[0!HB6MC8!87_]G:0M4%X4=V477';7
M19K)9"8SF<Q,7GKTOU[;1%WB,FI;7R)J3(D@8NFV0:WFETB'-Z)[D?]E-C>.
M6AS@ -9B7R(MSIV#>/SEY27VDHC9;C.N[N_OQWL")N(!'?2FPFF*HL;OKBZK
M>HNT<91:C&-+)X-*)K6>9N,7I0/0NFO2$*AX$C22B$^@AE)C6&$4>#?N%89
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M;!M(@A]^8N+F0P.;C+P'56H$5<$"N?1S@,O%9M$R2.^"]!\4,'')726M:._
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MF/^%0]T>T 5EY^M:H.UD:GKY!U!+ P04    "  )<FA7R=1UI_T*  " A@
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M>S.K/?(?4$L! A0#%     @ "7)H5TC++-Y7$   TTL   H
M ( !     &5X.3DM,2YH=&U02P$"% ,4    "  )<FA7Z0AZ8103  !SFP
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7;%!+!08     !0 % #8!  #;.0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
